common.study.topics.clinical

Testing Experimental Medication in Healthy Subjects

common.study.values.description

A Phase I Study of SB26 in Healthy Volunteers

This study is a Phase I, randomized double-blind, placebo-controlled (within a dose group), single and multiple rising dose study of the intravenous administration of SB26 in healthy volunteers.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - SB26

SB26 administered intravenously

Drug - Placebo

Placebo administered intravenously

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Randomized, Double-blind, Placebo-controlled, Single and Multiple Rising Dose Study to Explore the Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of SB26 in Healthy Volunteers

common.study.values.clinical-trial-id

NCT03630627

participant.views.study.view.id

eZ6Vwe